OLR1 and colonic neoplasm: LOX-1 knockdown using RNAi in DLD1 colon cancer cells influenced butyrate levels, with a marked increase in histone H4 acetylation, suggesting a link between LOX-1 signaling and the epigenetic control of tumor suppressor gene expression [153].